Selected Drugs Clear All
MultiCheck Results
- 3
Interactions
Avoid/Use Alternative |
||
|
Pirmella 1/35
(norethindrone/ ethinyl estradiol) + Reyataz
(atazanavir) |
||
Avoid/Use Alternativeethinyl estradiol (contraceptive) + atazanavir monitor thrombosis s/sx, especially if oral ethinyl estradiol dose at least 35 mcg/day; ATAZANAVIR W/ RITONAVIR: use additional non-hormonal or alternative contraception if ethinyl estradiol dose <35 mcg/day (induction predominates); ATAZANAVIR W/O RITONAVIR: avoid combo if ethinyl estradiol dose at least 30 mcg/day (inhibition predominates); ATAZANAVIR W/ COBICISTAT: consider additional non-hormonal or alternative contraception (effects unknown): combo may incr. or decr. ethinyl estradiol levels, incr. risk of thromboembolism, other adverse effects or decr. hormonal contraceptive efficacy (hepatic metabolism altered, UGT inhibited) Monitor/Modify Txnorethindrone (contraceptive) + atazanavir monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. norethindrone levels, risk of thromboembolism, other adverse effects (hepatic metabolism possibly inhibited) |
||
Monitor/Modify Tx |
||
|
Pirmella 1/35
(norethindrone/ ethinyl estradiol) + Reglan
(metoclopramide) |
||
Additional Considerations |
||
|
casirivimab (REGN10933)
in REGEN-COV
|
||
|
FDA emergency use authorization revoked |
||
|
imdevimab (REGN10987)
in REGEN-COV
|
||
|
FDA emergency use authorization revoked |
||